BCR and leukemia: In conclusion, this case underscores the clinical imperative of utilizing molecular diagnostics, particularly whole-transcriptome sequencing, in instances where conventional BCR::ABL1 assays yield negative results despite cytogenetic evidence of Ph+ leukemia.